Neuherberg, 05.05.2021

The 2021 Paul Langerhans Medal goes to Professor Dr. Dr. h.c. mult. Martin Hrabĕ de Angelis. The German Diabetes Association (DDG) thus honors his outstanding achievements in research into the genetic and epigenetic determinants of diabetes mellitus as well as his significant contribution to the foundation and development of the German Center for Diabetes Research (DZD).

Neuherberg, 05.05.2021

During its virtual congress (May 12-15, 2021), the German Diabetes Society (DDG) will honor several scientists from the German Center for Diabetes Research (DZD). The most prestigious award of the DDG, the Paul Langerhans Medal, will be conferred on Professor Dr. Dr. h.c. mult. Martin Hrabĕ de Angelis.

Neuherberg, 04.05.2021

Under the motto "Precision Medicine - a Journey into the Future of Diabetology", the 55th Annual Meeting of the German Diabetes Society (DDG) will take place digitally from May 12th. The German Center for Diabetes Research (DZD) is not only organizing four symposia at the congress, but is also presenting its interdisciplinary, translational research as well as its information services in numerous lectures and talks. An important focus of the DZD is on new approaches for precision diabetes therapy and prevention.

Düsseldorf, 28.04.2021

People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes. The question to be answered is whether all people with diabetes have an increased risk of severe COVID-19, or whether specific risk factors can also be identified within this group. A new study by DZD researchers has now focused precisely on this question and gained relevant insights.

Tübingen, 26.04.2021

Not everyone who has pre-diabetes with elevated blood glucose levels will go on to develop type 2 diabetes. Robert Wagner of the DZD partner Medical Clinic IV of Tübingen University Hospital has shown that there are six clearly definable subtypes that differ in the development of the disease, the risk of diabetes and the development of secondary diseases. For his findings, he was awarded the Prevention Award 2021 by the German Foundation for Internal Medicine (DSIM) and the German Society for Internal Medicine (DGIM).

Berlin, 14.04.2021

Research at the German Center for Diabetes Research (DZD) must be further intensified and a ban on advertising for unhealthy children's food should be a binding part of the next coalition agreement. Unfortunately, however, the round table of the Federal Ministry of Food and Agriculture (BMEL) on "Nutrition in Type 2 Diabetes" on April 13th ended without results. Federal Minister Julia Klöckner had invited scientists from the German Center for Diabetes Research (DZD) as well as representatives of the German Diabetes Society (DDG) and other associations. The DDG and DZD subsequently regret the open outcome and point out how important it is, for example, not only to tentatively regulate the advertising of unhealthy food to children, as recently agreed by the BMEL with The German Advertising Federation (ZAW), but to ban it.

Neuherberg, 08.04.2021

A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests. In addition, the researchers found that about eight times more children had antibodies against SARS-CoV-2 at the end of the second wave in comparison to the end of the first wave. The results are relevant for decision-making on which measures to take to contain the pandemic.

Düsseldorf, 08.04.2021

Chronic inflammation is increasingly a focus of research. A recent study has now identified differences in indicators of inflammation between novel diabetes subgroups. But what does this mean for the future?

Neuherberg, 31.03.2021

The protein Asc-1 regulates whether fat-burning beige or fat-storing white adipocytes are formed, which can have an impact on the development of metabolic diseases. This is shown by a current study of the Helmholtz Zentrum München and the German Center for Diabetes Research (DZD). The results open up new approaches to prevent the development of metabolic diseases. The study has now been published in 'Nature Communications'.

Düsseldorf, 19.03.2021

A new study by the German Diabetes Center shows that type 2 diabetes affects the energy metabolism in the human heart muscle. For this study, this year's Karl Oberdisse Award was presented to the scientist Elric Zweck.

Neuherberg, 03.03.2021

This year’s Berthold Medal, the highest recognition of the German Society of Endocrinology (DGE), goes to Professor Matthias Tschöp, who is CEO of Helmholtz Zentrum München and Alexander-von-Humboldt Professor at Technical University of Munich. Tschöp received the Berthold Medal at the 64th annual meeting of the DGE, the German Congress of Endocrinology, in recognition of his scientific achievements.

Düsseldorf, 01.03.2021

The Hans Adolf Krebs Prize was awarded for the 13th time by the German Nutrition Society. This year's prize winner is Yanislava Karusheva, MD, for her study on the influence of branched-chain amino acids on glucose metabolism in type 2 diabetes.

Potsdam-Rehbrücke, 24.02.2021

Young scientist Dr. Maximilian Kleinert joined the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) at the beginning of the year. Over the next five years, he and his team will investigate the molecular signaling pathways induced by physical activity that are involved in the regulation of glucose metabolism in skeletal muscle. This could help to develop new approaches for the prevention and treatment of type 2 diabetes.

Neuherberg, 10.02.2021

The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in 'Cell Metabolism', identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.

Berlin, 10.02.2021

Type 2 diabetes is not a disease that develops suddenly. Rather, it usually develops over a period of years from a preliminary stage known as prediabetes. Even if those affected are unaware that they have prediabetes and their blood glucose levels are still below the critical diagnostic threshold, their blood glucose regulation is already slightly impaired in this phase. However, people with prediabetes are not a homogeneous group, as physicians from Tübingen University Hospital, the Institute for Diabetes Research and Metabolic Diseases (IDM) of Helmholtz Zentrum München at the University of Tübingen and the German Center for Diabetes Research (DZD) show in the journal 'Nature Medicine'. Within the scope of a long-term study, they identified six subtypes of prediabetes that differ significantly in terms of risk factors, disease development and prognosis. According to the German Diabetes Society (DDG) and the DZD, this could result in important approaches for individually adapted preventive and therapeutic measures.

Düsseldorf, 04.02.2021

For the past seven years, DZD scientist PD Dr. Julia Szendrödi has headed the Clinical Study Center at the German Diabetes Center. Now she has accepted a professorship at the University of Heidelberg to take over as Medical Director of the Clinic for Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry at Heidelberg University Hospital – a further step along the path of her successful scientific career.

Neuherberg, 27.01.2021

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum München, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery. The blocking of inceptor function leads to an increased sensitisation of the insulin signaling pathway in pancreatic beta cells. This might allow protection and regeneration of beta cells for diabetes remission.

Potsdam-Rehbrücke, 19.01.2021

Successful weight loss is considered to be an integral part of the therapy for type 2 diabetes. Nevertheless, studies keep appearing that question the importance of losing weight. However, new data from a large-scale observational study carried out at DIfE in cooperation with the German Center for Diabetes Research (DZD) support the current recommendations of physicians. The findings, published in the journal 'Diabetologia', suggest that obesity and weight gain can lead to vascular disorders, the leading cause of disease and death for people with type 2 diabetes.

Düsseldorf, 18.01.2021

In recent years, air pollutants have been suggested as risk factors for diabetes and its – also mostly obesity-associated – comorbidities. Until now, however, this link has not been investigated for peripheral neuropathy. A new study by the German Diabetes Center (DDZ) and the Helmholtz Zentrum München has explored a possible association of air pollutants and the risk for peripheral neuropathy in humans.

Neuherberg, 10.01.2021

The gut plays a central role in the regulation of the body’s metabolism and its dysfunction is associated with a variety of diseases, such as obesity, diabetes, colitis and colorectal cancer that affect millions of people worldwide. Targeting endocrine dysfunction at an early stage by stimulating the formation of specific enteroendocrine cells from intestinal stem cells could be a promising regenerative approach for diabetes therapy. For this, however, a detailed understanding of the intestinal stem cell lineage hierarchy and the signals regulating the recruitment of the different intestinal cell types is critical.

Tübingen, 04.01.2021

All prediabetes is not the same: in people in the preliminary stages of type 2 diabetes, there are six clearly distinguishable subtypes, which differ in the development of the disease, diabetes risk, and the development of secondary diseases. This is shown in a study by the Institute for Diabetes Research and Metabolic Diseases (IDM) of Helmholtz Zentrum München at the University of Tübingen, Tübingen University Hospital and the German Center for Diabetes Research (DZD). The results have now been published in 'Nature Medicine'. The new classification can help in the future to prevent the manifestation of diabetes or the development of diabetes complications through targeted prevention.